• +33 (0)3 81 41 38 38
  • orders [at] medixbiochemica [dot] com

Search for products

Human IL-17A ELISA Kit

Product Specifications

Catalogue N°
850.940.048 - 1 x 48 Discovery (pre-coated)
850.940.096 - 1 x 96 (pre-coated)
850.940.192 - 2 x 96 (pre-coated)
Assay Range
3.125 pg/ml - 1000 pg/ml
Sensitivity
2.3 pg/ml
Target species
Human
Specificity
Recognizes both natural and recombinant human IL-17A
Incubation
3h45
Sample Type
Serum, Plasma, Cell culture supernatant
Sample Size
100 µl (50µl for serum/plasma)
Cross Reaction
No cross reaction with other human cytokines
Kit Content
Diaclone ELISA Kits include pre-coated strip plates, biotinylated secondary antibody, standards, controls (where applicable), buffers, streptavidin-HRP, TMB, stop reagents and a detailed procedure.
IL-17A ELISA Kit
Example of Human IL-17A Standard Curve

References

  • Altokka-Uzun, G. et al., Cephalalgia, 2015: 333102415570762 - Pubmed link
  • Corvaisier, M. et al., PLoS Biol.,2012;10(9): e1001395 - Pubmed link
  • Cunin, P. et al., J. Immunol.,2011;186(7): 4175-4182. - Pubmed link
  • Darmochwal-Kolarz, D. et al.,Biomed Res Int. 2017;2017:6904325. - Pubmed link
  • Esfahanian, F. et al.,Indian J Endocrinol Metab. 2017 Jul-Aug;21(4):551-554 - Pubmed link
  • Giris, M. et al.,In Vivo. 2017 Jul-Aug;31(4):657-660. - Pubmed link
  • Kanda, K., et al., Exerc Immunol Rev.,2014;20:39-54 - Pubmed link
  • Krasimirova,E. et al., World J Exp Med., 2017 Aug 20;7(3):84-96. - Pubmed link
  • Liao, B. et al.,Emerg Microbes Infect.,2015; 4(4): e24 - Pubmed link
  • Lu, C. et al., Lupus, 2015;24(1):18-24 - Pubmed link
  • Madej, M. et al., Reumatologia,2015; 53(1): 9-13. - Pubmed link
  • Maruyama, K. et al., J. Biol. Chem.,2016;291(46):23854-23868 - Pubmed link
  • Mateen,S. et al.,PLoS One. 2017 Jun 8;12(6):e0178879 - Pubmed link
  • Okada, K. et al., PeerJ.,2017; 5: e2999. - Pubmed link
  • Rai, G. et al.,Ann Lab Med., 2018 Mar;38(2):125-131 - Pubmed link
  • Rana, A. et al.,Lupus,2012; 21(10): 1105-1112 - Pubmed link
  • Rybka, J. et al.,Clin Exp Med.,2015; 16(4): 493-502. - Pubmed link
  • Sun, X. et al., Nutrients,2014;6(1): 221-30 - Pubmed link
  • Tsvetkova-Vicheva, V. M. et al.,Clin Transl Allergy,2014; 4(1): 3 - Pubmed link
  • Wlodarczyk, M. et al.,World J Gastroenterol.,2014;20(22): 7019-26 - Pubmed link
  • Demir, E. et al.,Biomolecules. 2019 Mar 11;9(3). pii: E97 - Pubmed link
  • Iida, K. et al., Oncol Lett. 2019 Apr;17(4):4004-4010. - Pubmed link
  • Velikova, T. et al., Medicina (Kaunas). 2019 May 15;55(5). pii: E136 - Pubmed link
  • Rai, G. et al., Microb Cell Fact. 2020; 19: 215. - Pubmed link
  • KÖŞger, F. et al., Noro Psikiyatr Ars. 2020 Dec; 57(4): 303–307. - Pubmed link
  • Chenniappan, R. et al., Ann Neurosci. 2020 Jan; 27(1): 24–28. - Pubmed link
  • Zielińska, K. et al., J Immunol Res. 2020; 2020: 3928504. - Pubmed link
  • Krawiec, P. et al., Sci Rep. 2020; 10: 12617. - Pubmed link
  • Velikova, T. et al., Nutrients. 2020 Jun; 12(6): 1706. - Pubmed link
  • Reale, M. et al., Int J Mol Sci. 2020 May; 21(9): 3264. - Pubmed link
  • Velikova, T. V. et al., World J Gastroenterol. 2020 Apr 28; 26(16): 1912–1925. - Pubmed link
  • Costantini, E. et al., Int J Mol Sci. 2020 Apr; 21(8): 2669. - Pubmed link
  • Hashemi, R. et al., PLoS One. 2020; 15(4): e0231145. - Pubmed link
  • Zhao, J. et al., Infect Drug Resist. 2020; 13: 835–843. - Pubmed link
  • Żyżyńska-Granica, B. et al., Sci Rep. 2020; 10: 2886. - Pubmed link
  • Techatanawat, S. et al., PLoS One. 2020; 15(2): e0228921. - Pubmed link
  • Lima-Cabello, E. et al., Antioxidants (Basel) 2020 Jan; 9(1): 12. - Pubmed link
  • Jaszczura, M. et al., Rheumatol Int. 2019; 39(11): 1945–1953. - Pubmed link
  • Guloksuz, S. A. et al., Braz J Psychiatry. 2017; 39(3): 195–200. - Pubmed link
  • Divyapriya, D. et al., Postepy Dermatol Alergol. 2021 Oct; 38(5): 858–865. - Pubmed link
  • Mary, A.P. et al., Int J Reprod Biomed. 2021 Apr; 19(4): 333-338. - Pubmed link
  • Singh, A. et al., Indian J Dermatol. 2021 May-Jun; 66(3): 291–296. - Pubmed link
  • Kryczyk-Kozioł, J. et al., Nutrients. 2022 Jul; 14(14): 2869. - Pubmed link
  • Tomaszewska, K.A. et al., Postepy Dermatol Alergol. 2022 Feb; 39(1): 195–199. - Pubmed link
  • Cristiani, C.M. et al., Front Immunol. 2022; 13: 811131. - Pubmed link
  • Kula, A. et al., Medicina (Kaunas) 2022 Jan; 58(1): 96. - Pubmed link

BACKGROUND

Interleukin-17 (IL-17, or IL-17A) is the founding member of a group of cytokines called the IL-17 family. IL-17A, was originally identified as a transcript from a rodent T-cell hybridoma by Rouvier et al. in 1993.

IL-17A is involved in inducing and mediating proinflammatory responses, commonly associated with allergic responses and induces the production of many other cytokines (such as IL-6, G-CSF, GM-CSF, IL-1β, TGF-β, TNF-α), chemokines (including IL-8, GRO-α and MCP-1) and prostaglandins (e.g. PGE2) from many cell types (fibroblasts, endothelial cells, epithelial cells, keratinocytes and macrophages).

IL-17A function is also essential to a subset of CD4+ T-Cells called T helper 17 (Th17) cells.

Version 17 - 09.22

For research use only

Documents

print Request more information

For any order, the purchaser acknowledges having read and accepted the terms and conditions described on the Diaclone website.

Formats Available

850.940.048 1 x 48 Discovery (pre-coated)
850.940.096 1 x 96 (pre-coated)
850.940.192 2 x 96 (pre-coated)

Ordering options

Place an order
by phone: +33 (0)3 81 41 38 38
or by email: info [at] diaclone [dot] com ( Subject: Diaclone's order, Body: Human IL-17A ELISA Kit 850.940.048 - 1 x 48 Discovery (pre-coated) 850.940.096 - 1 x 96 (pre-coated) 850.940.192 - 2 x 96 (pre-coated) )

Please contact us to discuss bulk orders